Our Sites use cookies for analytics purposes. For more information about the cookies we use on our Sites or how you can disable them, please see our Cookie Policy.

October 2022

Alexandra Davin, Vice President Global Quality & Compliance, Pharma & Healthcare.
October 18, 2022

JAS Worldwide is pleased to announce the appointment of Alexandra Davin as Vice President Global Quality & Compliance, Pharma & Healthcare, strengthening the JAS Pharma & Healthcare leadership team. As a true customer-centric, disciplined, and collaborative quality leader, her +20 years of background includes various leadership positions from operations to sales and quality & compliance, leading global quality programs for the large pharma & healthcare customers.

Alexandra led all quality aspects of GDP certifications and licenses, IATA CEIV certifications, and other certifications, dealing with CAPA, training, internal and external audits, creation and maintenance of procedures and work instructions, review of quality agreement, creation and management of Quality KPIs, and many more.

All regional heads of pharma & healthcare quality &compliance will be reporting to Alexandra for JAS Pharma & Healthcare Quality & Compliance direction and strategy. She will continue to be based in Belgium, reporting directly to David Bang, EVP Pharma & Healthcare at JAS Worldwide.

“Her outstanding global quality leadership experience will help bring pharma & healthcare quality topics closer to our day to day operations, making our branches and subsidiaries’ lives more productive and confident towards the current and the future pharma & healthcare regulatory requirements.” said Bang.